1. Cruz, E. P., McDonald, G. O. and Cole, W. H.: Prophylactic treatments of cancer. The use of chemotherapeutic agents to prevent tumor metastasis. Surgery, 40: 291–296, 1956.
2. Hattori, T., Mori, A., Hirata, K. and Ito, I.: Five year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C and/or allogeneic bone marrow transplantation. GANN, 63: 517–522, 1972.
3. Horwitz, H., Wright, T. L., Perry, H. and Barrett, C. M.: “Suppressive” chemotherapy in bronchogenic carcinoma. A randomized prospective clinical trial. Amer. J. Roentgen., 93: 615–638, 1965.
4. Inokuchi, K., Nakamura, T., Ienaga, S., Akiyoshi, T. and Ikeda, T.: Spleen and bone marrow shielding technique in intraoperative adjuvant chemotherapy for gastric cancer. J. Antibiotics, Ser, A., 19: 78–84, 1966.
5. Karrer, K.: Importance of dose schedule in adjuvant chemotherapy. Cancer Chemoth. Rep., 56: 35–45, 1972.